Stephan Kutzer, Ph.D.
Chief Executive Officer
Stephan Kutzer, Ph.D is the President & CEO of Alcami Corporation.
A proven forward-thinking executive leader, Dr. Kutzer brings to Alcami over 20 years of experience in the pharmaceutical and biotech industry, building and managing large contract services enterprises.
Prior to Alcami, Dr. Kutzer was Chief Operating Officer of Lonza’s Pharma and Biotech division, part of the global chemicals and biotechnology company, Lonza Group. He also served as Chief Operating Officer and President for several other Lonza branches, including Custom Manufacturing, Biopharmaceuticals, TL Biopharmaceuticals and Performance Chemicals.
Under Dr. Kutzer’s leadership Alcami introduced the unique service offering of fully integrated end-to-end solutions to the CDMO sector focusing on the individual clinical and early commercial needs of small and mid-size pharmaceutical and biotech companies.
Dr. Kutzer was recently elected to his third term on the Drug, Chemical and Associated Technologies Association (DCAT) Board of Directors. He begins this term as First Vice President, having previously served as Second and Third Vice President. Dr. Kutzer lends to the board his skillful methodologies to developing and guiding strategic planning, policy establishment and implementation, and financial management.
Dr. Kutzer earned a Master’s Degree in Chemical and Process Engineering and a Ph.D. in Engineering Sciences (Chemical Engineering) from the Technical University of Munich, Germany.